Robert C. Bast

Department of Experimental Therapeutics University of Texas M.D. Anderson Cancer Center 
"Robert Bast"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Handley KF, Sims TT, Bateman NW, et al. (2022) Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics. Jama Network Open. 5: e2236626
Irajizad E, Han CY, Celestino J, et al. (2022) A blood-based metabolite panel for distinguishing ovarian cancer from benign pelvic masses. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Boylan KLM, Petersen A, Starr TK, et al. (2022) Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer. Cancers. 14
Shi X, Yu X, Wang J, et al. (2022) SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK. Molecular Oncology
Blackman A, Mitchell J, Rowswell-Turner R, et al. (2021) Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumors. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 43: 355-365
Bast RC, Han CY, Lu Z, et al. (2021) Next steps in the early detection of ovarian cancer. Communications Medicine. 1
Bildik G, Liang X, Sutton MN, et al. (2021) DIRAS3: An Imprinted tumor suppressor gene that regulates RAS and PI3K-driven cancer growth, motility, autophagy and tumor dormancy. Molecular Cancer Therapeutics
Artibani M, Masuda K, Hu Z, et al. (2021) Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells. Jci Insight
Fan D, Yang H, Mao W, et al. (2021) A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin. Cancers. 13
Kim O, Park EY, Kwon SY, et al. (2020) Targeting progesterone signaling prevents metastatic ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America
See more...